Skip to content

Innotherapy, Inc.

South KoreaFDA applicant, unverified

Devices
1

What Innotherapy, Inc. makes

Innotherapy, Inc. manufactures the InnoSEAL Hemostatic Pad, a device designed to control bleeding by applying pressure and promoting clotting at wound sites.

The InnoSEAL Hemostatic Pad is classified as a Class II (U) device under FDA regulations and is listed via a 510(k) clearance. The company is based in the United States.

AI-generated from registry data, 2 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue1

Newest first, rows 1-1 of 1

  • InnoSEAL Hemostatic Pad Ref K161013

    Active Regimes: 510(k) Registry: 510(k) Class:—

Frequently asked questions

How many devices does Innotherapy, Inc. have in the registry?

The registry currently lists 1 device for Innotherapy, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Innotherapy, Inc.'s devices?

Among its 1 most recently registered device, Innotherapy, Inc. has devices listed in FDA 510(k) (1 device).

What are the newest devices from Innotherapy, Inc. in the registry?

The most recently registered devices listed for Innotherapy, Inc. include InnoSEAL Hemostatic Pad.

Generated automatically from registry data and not verified by a human reviewer.